Sign inJoin waitlistJoin the waitlist

Seong Cho

Director, Division of Allergy & Immunology · University of South Florida Morsani College of Medicine

Credentials: · · · ·

History

Allergy and Immunology
1992–1993
Internal Medicine
1989–1992
Kyung Hee University College of Medicine
1985–1989

Research

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre,…
The Lancet · 2019 · 1,250 citations
NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation
Cell Death and Disease · 2014 · 173 citations
Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976-2022: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · Clinical Gastroenterology and Hepatology · 2023 · 158 citations

Richard Lockey
13 papers
CO
Chad Oh
12 papers
Robert Schleimer
11 papers
Anju Peters
4 papers
Joseph Han
4 papers
Leslie Grammer
4 papers
PA
Pedro Avila
4 papers
Stella Lee
4 papers
TL
Tanya Laidlaw
4 papers
Bruce Tan
3 papers
David Conley
3 papers
Dennis Ledford
3 papers

Grants

Age Related Differences in Chronic Rhinosinusitis and Nasal Polyps
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $675K · University of South Florida
2014–2020

Clinical trials

Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
Principal investigator · Active not recruiting · Phase 2
University of South Florida
2020–2025
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2024–2028